| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/21/2004 | DE20221037U1 Container for liquid sample holders for river water, drinking water or liquid effluent comprises outer storage container with first closure which is removed and replaced during transport with second closure |
| 10/21/2004 | DE10326612B3 Process for measuring the temperature inside a liquid or solid medium, especially a glass melt, a crystal melt or salt melt, comprises measuring the electrical potential and the temperature when a current is passed between measuring points |
| 10/21/2004 | DE10313324A1 Preparing sorbent having at least two groups for selective binding, useful, e.g. for detecting receptor-agent interaction, in drug screening and in substrate separation or purification |
| 10/21/2004 | DE10313116A1 Verfahren und Vorrichtung zur Bestimmung des Feststoffgehalts einer Suspension Method and apparatus for determining the solids content of a suspension |
| 10/21/2004 | DE10309349A1 Apparatus for the analysis of an analyte such as a foodstuff, feces, water or fermenter sample, comprises a semiconductor chip carrier with immobilized receptors specific for particular ligands, and a pH sensor |
| 10/21/2004 | DE102004014338A1 Verfahren zum Bestimmen der Eigenschaften einer Stoffprobe A method for determining the properties of a material sample |
| 10/21/2004 | DE102004014145A1 Gaskonzentrationsmessgerät Gas concentration measuring apparatus |
| 10/21/2004 | CA2807564A1 Microfluidic devices and methods of using same |
| 10/21/2004 | CA2526878A1 A method for detection of colorectal cancer in human samples |
| 10/21/2004 | CA2523186A1 Method of screening drug with the use of 67 kda laminin receptor and drug obtained thereby |
| 10/21/2004 | CA2522333A1 Methods for treating proliferative diseases and for monitoring the effectiveness of treatment of proliferative diseases |
| 10/21/2004 | CA2521904A1 Caries risk test for predicting and assessing the risk of disease |
| 10/21/2004 | CA2521614A1 Method of determining xenograft responses |
| 10/21/2004 | CA2521613A1 Surface-immobilised multilayer structure of vesicles |
| 10/21/2004 | CA2521486A1 Method of analysing the cytoskeletal protein of cells |
| 10/21/2004 | CA2521438A1 Prion protein binding materials and methods of use |
| 10/21/2004 | CA2521414A1 Methods to individualize combination therapy |
| 10/21/2004 | CA2521402A1 Pectate lyases, nucleic acids encoding them and methods for making and using them |
| 10/21/2004 | CA2521303A1 The use of pde4d in the screening for medicaments against atherosclerosis |
| 10/21/2004 | CA2521273A1 Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production |
| 10/21/2004 | CA2521136A1 Methods of determining efficacy of treatments of inflammatory diseases of the bowel |
| 10/21/2004 | CA2521048A1 Anti-retroviral analysis by mass spectrometry |
| 10/21/2004 | CA2520987A1 Targets for tumor growth inhibition |
| 10/21/2004 | CA2520875A1 Methods for rational pegylation of proteins |
| 10/21/2004 | CA2520028A1 Compounds and methods to enhance raav transduction |
| 10/21/2004 | CA2520016A1 Pharmico-gene therapy of epithelial sodium channel associated disorders |
| 10/21/2004 | CA2519626A1 Thyroid hormone analysis by mass spectrometry with minimal sample preparation |
| 10/21/2004 | CA2519557A1 Steroid hormone analysis by mass spectrometry |
| 10/21/2004 | CA2519411A1 Obtaining product item assistance |
| 10/21/2004 | CA2485416A1 Method of measuring freshness of cereals and beans and apparatus therefor |
| 10/20/2004 | EP1469317A1 Reagent for detecting anti-phospholipid antibody |
| 10/20/2004 | EP1469316A1 Screening method |
| 10/20/2004 | EP1469315A1 Method of mass spectrometry |
| 10/20/2004 | EP1469314A1 Method of mass spectometry |
| 10/20/2004 | EP1469313A1 Method of mass spectrometry |
| 10/20/2004 | EP1469312A1 Diagnosis of Alzheimer's disease |
| 10/20/2004 | EP1469311A1 Biosensor, magnetic molecule measurement method, and measurement object measuring method |
| 10/20/2004 | EP1469310A1 Diagnostic for scleroderma |
| 10/20/2004 | EP1469309A1 Method of evaluating cell activity |
| 10/20/2004 | EP1469308A1 Method of screening drug |
| 10/20/2004 | EP1469301A1 An apparatus for optically checking the exterior quality of bulbous fruits and vegetable products of various shapes and sizes |
| 10/20/2004 | EP1469090A2 Combinatorial production by diffusion of material compositions from a single sample |
| 10/20/2004 | EP1469084A2 Polymorphisms in the human KDR gene |
| 10/20/2004 | EP1469076A2 Recombinant PRRS proteins, diagnostic kits and vaccines containing said recombinant proteins |
| 10/20/2004 | EP1469072A2 Means and methods for diagnosing and treating affective disorders |
| 10/20/2004 | EP1469071A1 Method of screening drug for improving insulin resistance |
| 10/20/2004 | EP1469067A1 Method and apparatus for detecting nucleic acid data |
| 10/20/2004 | EP1468726A1 Beads alignment structure, production method thereof, and bead alignment method for capillary beads array |
| 10/20/2004 | EP1468694A1 Remedies for anorexia or lifestyle-related diseases and method of screening the same |
| 10/20/2004 | EP1468641A2 Blood oxygen monitoring system and a lead therefor |
| 10/20/2004 | EP1468392A2 Method for binding site identification using a multi-scale approach |
| 10/20/2004 | EP1468295A2 Water- soluble derivatives of lipophilic drugs |
| 10/20/2004 | EP1468294A2 Internal standards for sphingolipids for use in mass spectrometry |
| 10/20/2004 | EP1468293A1 Diagnostic and therapeutic use of the voltage-gated ion channel scn2a for neurodegenerative diseases |
| 10/20/2004 | EP1468292A1 Diagnostic methods |
| 10/20/2004 | EP1468291A1 A label-free high throughput optical technique for detecting biomolecular interactions. |
| 10/20/2004 | EP1468290A2 A guided mode resonant filter biosensor using a linear grating surface structure |
| 10/20/2004 | EP1468288A2 Compositions and methods for accurate early pregnancy diagnosis |
| 10/20/2004 | EP1468287A2 AUTOMATED SYSTEMS AND METHODS FOR ANALYSIS OF PROTEIN POST−TRANSLATIONAL MODIFICATION |
| 10/20/2004 | EP1468286A2 Integrated protein affinity capture centrifugation device |
| 10/20/2004 | EP1468285A1 Method for detecting the biocompatibility of polymers |
| 10/20/2004 | EP1468283A1 Method for screening biological samples for presence of the metabolic syndrome |
| 10/20/2004 | EP1468282A2 Construction and use of micro-electrode arrays |
| 10/20/2004 | EP1468281A1 Diagnostic sensing apparatus |
| 10/20/2004 | EP1468277A1 Detection of molecular probes fixed to an active zone of a sensor |
| 10/20/2004 | EP1468274A1 Potassium fluoroionophore |
| 10/20/2004 | EP1468267A1 Method and apparatus for real-time monitoring of furnace flue gases |
| 10/20/2004 | EP1468265A1 Systems and methods for the analysis of protein phosphorylation |
| 10/20/2004 | EP1468120A1 Chemical proteomics |
| 10/20/2004 | EP1468118A2 Methods and compositions for treating cancer |
| 10/20/2004 | EP1468116A2 Method for isolating nucleic acids and protein from a single sample |
| 10/20/2004 | EP1468115A1 Method and test kit for demonstrating genetic identity |
| 10/20/2004 | EP1468114A1 Late-pcr |
| 10/20/2004 | EP1468109A1 Non- or minimally invasive monitoring methods |
| 10/20/2004 | EP1468107A2 Methods and reagents for improved cell-based assays |
| 10/20/2004 | EP1468098A2 Method of inhibiting pathogenicity of infectious agents |
| 10/20/2004 | EP1468097A2 METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM V sb H /sb AND V sb L /sb DOMAINS |
| 10/20/2004 | EP1468092A2 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 10/20/2004 | EP1468091A2 Transmembrane protein |
| 10/20/2004 | EP1468082A1 Crystal structure of phosphodiesterase 5 and use thereof |
| 10/20/2004 | EP1468081A1 Tyrosine kinase inhibitors |
| 10/20/2004 | EP1468023A2 Binding proteins as biosensors |
| 10/20/2004 | EP1468019A2 Secreted protein |
| 10/20/2004 | EP1468018A2 Leptin proteins |
| 10/20/2004 | EP1468017A1 A complex of a human foxc2 protein and a foxc2-interacting protein |
| 10/20/2004 | EP1468008A2 MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) PROMOTER POLYMORPHISM IN INFLAMMATORY DISEASE |
| 10/20/2004 | EP1467915A2 Apparatus and method for monitoring environment within a container |
| 10/20/2004 | EP1467817A1 Apparatus for retaining magnetic particles within a flow-through cell |
| 10/20/2004 | EP1467815A1 Reaction vessel for carrying out array processes |
| 10/20/2004 | EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS |
| 10/20/2004 | EP1467715A1 Formulations for oral administration of active compounds |
| 10/20/2004 | EP1467616A2 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances |
| 10/20/2004 | EP1368651A4 Methods and material for evaluating cardiovascular conditions |
| 10/20/2004 | EP1322455B1 Predicting behaviour of a moulded composite component |
| 10/20/2004 | EP1285114A4 Methods for analyzing boron-containing alkaline pulping liquors |
| 10/20/2004 | EP1280465A4 Microfluidic channel embryo and/or oocyte handling, analysis and biological evaluation |
| 10/20/2004 | EP1204741B1 Simultaneous isolation and quantitation of dna |
| 10/20/2004 | EP1198477B1 Prolactin-releasing peptide and use in treating pain |
| 10/20/2004 | EP1179179B1 Use of an antibody to detect basophiles and/or mast cells |
| 10/20/2004 | EP1175510A4 Mismatch repair detection |